DOUGLAS P BAKER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DOUGLAS P BAKER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DOUGLAS P BAKER. DOUGLAS P BAKER is Chief Financial Officer in PEN INC. ($PENC) and Chief Financial Officer in OptimizeRx Corp ($OPRX).
Latest Insider Trading Transactions of DOUGLAS P BAKER
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 7.51 | 4,315 | 32,406 | 107,134 | |
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 7.51 | 4,315 | 32,406 | 90,217 | 85.9 K to 90.2 K (+5.02 %) |
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 47.25 | 5,032 | 237,762 | 85,902 | 90.9 K to 85.9 K (-5.53 %) |
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 7.51 | 4,315 | 32,406 | 107,134 | |
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 7.51 | 4,315 | 32,406 | 90,217 | 85.9 K to 90.2 K (+5.02 %) |
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 47.25 | 5,032 | 237,762 | 85,902 | 90.9 K to 85.9 K (-5.53 %) |
Jan 15 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 7.51 | 5,000 | 37,550 | 96,993 | |
Jan 15 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 7.51 | 5,000 | 37,550 | 90,937 | 85.9 K to 90.9 K (+5.82 %) |
Jan 15 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 7.51 | 5,000 | 37,550 | 96,993 | |
Jan 15 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 38.89 | 5,000 | 194,450 | 85,937 | 90.9 K to 85.9 K (-5.50 %) |
Jan 15 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 7.51 | 5,000 | 37,550 | 90,937 | 85.9 K to 90.9 K (+5.82 %) |
Jan 15 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 38.89 | 5,000 | 194,450 | 85,937 | 90.9 K to 85.9 K (-5.50 %) |
Jan 11 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | A | 37.50 | 14,456 | 542,100 | 116,449 | |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 7.51 | 4,000 | 30,040 | 101,993 | |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 2.46 | 4,566 | 11,232 | 105,993 | |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 7.51 | 4,000 | 30,040 | 90,937 | 86.9 K to 90.9 K (+4.60 %) |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 7.51 | 4,000 | 30,040 | 101,993 | |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 2.46 | 4,566 | 11,232 | 86,937 | 82.4 K to 86.9 K (+5.54 %) |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 2.46 | 4,566 | 11,232 | 105,993 | |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 32.88 | 8,334 | 274,022 | 82,371 | 90.7 K to 82.4 K (-9.19 %) |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 7.51 | 4,000 | 30,040 | 90,937 | 86.9 K to 90.9 K (+4.60 %) |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 2.46 | 4,566 | 11,232 | 86,937 | 82.4 K to 86.9 K (+5.54 %) |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 32.88 | 8,334 | 274,022 | 82,371 | 90.7 K to 82.4 K (-9.19 %) |
Nov 13 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 2.46 | 15,000 | 36,900 | 110,559 | |
Nov 13 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 2.46 | 15,000 | 36,900 | 90,705 | 75.7 K to 90.7 K (+19.81 %) |
Nov 13 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 24.05 | 15,000 | 360,750 | 75,705 | 90.7 K to 75.7 K (-16.54 %) |
Sep 04 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 2.46 | 10,000 | 24,600 | 125,559 | |
Sep 04 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 2.46 | 10,000 | 24,600 | 90,705 | 80.7 K to 90.7 K (+12.39 %) |
Sep 04 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 20.00 | 10,000 | 200,000 | 80,705 | 90.7 K to 80.7 K (-11.02 %) |
Sep 04 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 2.46 | 10,000 | 24,600 | 125,559 | |
Sep 04 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 2.46 | 10,000 | 24,600 | 90,705 | 80.7 K to 90.7 K (+12.39 %) |
Sep 04 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 20.00 | 10,000 | 200,000 | 80,705 | 90.7 K to 80.7 K (-11.02 %) |
Aug 14 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 2.46 | 10,000 | 24,600 | 135,559 | |
Aug 14 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 2.46 | 10,000 | 24,600 | 110,671 | 100.7 K to 110.7 K (+9.93 %) |
Aug 14 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 18.00 | 10,000 | 180,000 | 100,671 | 110.7 K to 100.7 K (-9.04 %) |
Aug 07 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 2.46 | 10,000 | 24,600 | 145,559 | |
Aug 07 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 2.46 | 10,000 | 24,600 | 110,671 | 100.7 K to 110.7 K (+9.93 %) |
Aug 07 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 17.01 | 10,000 | 170,100 | 100,671 | 110.7 K to 100.7 K (-9.04 %) |
Jul 17 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 2.46 | 8,000 | 19,680 | 155,559 | |
Jul 17 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 2.46 | 8,000 | 19,680 | 90,671 | 82.7 K to 90.7 K (+9.68 %) |
Jul 17 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 15.00 | 6,667 | 100,005 | 82,671 | 89.3 K to 82.7 K (-7.46 %) |
Mar 13 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | A | 7.51 | 63,558 | 477,321 | 186,861 | |
Jan 30 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | Chief Financial Off ... | Option Exercise | M | 3.15 | 5,032 | 15,851 | 123,303 | |
Jan 30 2020 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | Chief Financial Off ... | Buy | M | 3.15 | 5,032 | 15,851 | 71,917 | 66.9 K to 71.9 K (+7.52 %) |
Nov 07 2019 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | Chief Financial Off ... | Option Exercise | M | 3.15 | 5,000 | 15,750 | 128,335 | |
Nov 07 2019 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | Chief Financial Off ... | Buy | M | 3.15 | 5,000 | 15,750 | 66,885 | 61.9 K to 66.9 K (+8.08 %) |
May 13 2019 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 3.15 | 8,334 | 26,252 | 0 | |
May 13 2019 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 3.15 | 8,334 | 26,252 | 61,885 | 53.6 K to 61.9 K (+15.56 %) |
May 03 2019 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 3.15 | 5,000 | 15,750 | 8,334 | |
May 03 2019 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 3.15 | 5,000 | 15,750 | 53,551 | 48.6 K to 53.6 K (+10.30 %) |
Mar 29 2019 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | C | 0.00 | 16,667 | 0 | 10,000 | |
Mar 29 2019 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Grant | A | 0.00 | 16,667 | 0 | 48,551 | 31.9 K to 48.6 K (+52.27 %) |
Feb 26 2019 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.00 | 10,000 | 0 | 26,667 | |
Jan 03 2019 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 3.15 | 5,000 | 15,750 | 13,334 | |
Jan 03 2019 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 3.15 | 5,000 | 15,750 | 31,884 | 26.9 K to 31.9 K (+18.60 %) |
Aug 10 2018 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 3.15 | 15,000 | 47,250 | 151,669 | |
Aug 10 2018 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 3.15 | 15,000 | 47,250 | 26,884 | 11.9 K to 26.9 K (+126.22 %) |
Aug 10 2018 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 12.05 | 1,000 | 12,050 | 11,884 | 12.9 K to 11.9 K (-7.76 %) |
Aug 10 2018 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 12.01 | 1,000 | 12,010 | 12,884 | 13.9 K to 12.9 K (-7.20 %) |
Aug 10 2018 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 12.00 | 2,000 | 24,000 | 13,884 | 15.9 K to 13.9 K (-12.59 %) |
Aug 10 2018 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 12.00 | 784 | 9,408 | 15,884 | 16.7 K to 15.9 K (-4.70 %) |
Feb 02 2018 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | Chief Financial Off ... | Option Exercise | A | 0.00 | 50,000 | 0 | 550,000 | |
May 15 2017 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | P | 0.77 | 10,000 | 7,700 | 50,000 | 40 K to 50 K (+25.00 %) |
Nov 14 2016 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | P | 0.85 | 10,000 | 8,500 | 40,000 | 30 K to 40 K (+33.33 %) |
Jun 08 2016 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | P | 1.05 | 10,000 | 10,500 | 30,000 | 20 K to 30 K (+50.00 %) |
Jun 26 2015 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | Chief Financial Off ... | Option Exercise | A | 1.05 | 100,000 | 105,000 | 200,000 | |
Jan 02 2009 | PENC | PEN INC. | BAKER DOUGLAS P | Chief Financial Off ... | Option Exercise | A | 0.28 | 62,500 | 17,500 | 943,000 | |
May 04 2007 | PENC | PEN INC. | BAKER DOUGLAS P | Chief Financial Off ... | Option Exercise | M | 0.58 | 32,000 | 18,560 | 943,000 | |
May 04 2007 | PENC | PEN INC. | BAKER DOUGLAS P | Chief Financial Off ... | Buy | M | 0.58 | 32,000 | 18,560 | 59,500 | 27.5 K to 59.5 K (+116.36 %) |
Oct 16 2006 | PENC | PEN INC. | BAKER DOUGLAS P | Chief Financial Off ... | Buy | P | 1.05 | 5,000 | 5,250 | 27,500 | 22.5 K to 27.5 K (+22.22 %) |
Oct 11 2006 | PENC | PEN INC. | BAKER DOUGLAS P | Chief Financial Off ... | Option Exercise | G | 0.63 | 100,000 | 62,500 | 975,000 | |
Oct 11 2006 | PENC | PEN INC. | BAKER DOUGLAS P | Chief Financial Off ... | Buy | P | 1.09 | 3,500 | 3,815 | 22,500 | 19 K to 22.5 K (+18.42 %) |
Oct 11 2006 | PENC | PEN INC. | BAKER DOUGLAS P | Chief Financial Off ... | Buy | P | 1.10 | 4,500 | 4,950 | 19,000 | 14.5 K to 19 K (+31.03 %) |
Oct 11 2006 | PENC | PEN INC. | BAKER DOUGLAS P | Chief Financial Off ... | Buy | P | 1.11 | 5,000 | 5,550 | 14,500 | 9.5 K to 14.5 K (+52.63 %) |
Jan 04 2005 | PENC | PEN INC. | BAKER DOUGLAS P | Chief Financial Off ... | Option Exercise | A | 2.17 | 100,000 | 217,000 | 1,075,000 | |
Jan 04 2005 | PENC | PEN INC. | BAKER DOUGLAS P | Chief Financial Off ... | Option Exercise | A | 2.17 | 100,000 | 217,000 | 975,000 | |
Jan 04 2005 | PENC | PEN INC. | BAKER DOUGLAS P | Chief Financial Off ... | Option Exercise | J | 2.93 | 100,000 | 293,000 | 875,000 | |
Jan 04 2005 | PENC | PEN INC. | BAKER DOUGLAS P | Chief Financial Off ... | Option Exercise | J | 2.93 | 100,000 | 293,000 | 975,000 | |
Jan 04 2005 | PENC | PEN INC. | BAKER DOUGLAS P | Chief Financial Off ... | Option Exercise | A | 2.17 | 50,000 | 108,500 | 1,075,000 | |
Jan 27 2004 | PENC | PEN INC. | BAKER DOUGLAS P | Chief Financial Off ... | Option Exercise | A | 2.93 | 250,000 | 732,500 | 1,025,000 | |
Jan 27 2004 | PENC | PEN INC. | BAKER DOUGLAS P | Chief Financial Off ... | Option Exercise | A | 2.93 | 100,000 | 293,000 | 775,000 |
Page: 1